Structural basis of integrin regulation and signaling

Annual Review of Immunology

Volumn 25, Issue , 2007, Pages 619-647

  Luo, Bing Hao ^a   Carman, Christopher V ^a   Springer, Timothy A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cell adhesion; Conformational change; I domain; ICAM 1; Migration

Indexed keywords

ALPHA1 INTEGRIN; BETA1 INTEGRIN; CALCIUM; CYTOPLASM PROTEIN; HYBRID PROTEIN; INTEGRIN; LIGAND; MANGANESE; MEMBRANE PROTEIN;

AFFINITY LABELING; CELL MEMBRANE; CELL SURFACE; CELLULAR DISTRIBUTION; DYNAMICS; LIGAND BINDING; MODULATION; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL ADHESION; CELL MOVEMENT; EXTRACELLULAR MATRIX; HUMANS; INTEGRINS; LEUKOCYTES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34247891506     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.25.022106.141618     Document Type: Review

References (128)

1. Pribila JT, Quale AC, Mueller KL, Shimizu Y. 2004. Integrins and T cell-mediated immunity. Annu. Rev. Immunol. 22:157-80
2. Kinashi T. 2005. Intracellular signaling controlling integrin activation in lymphocytes. Nat. Rev. Immunol. 5:546-59
3. Anderson DC, Springer TA. 1987. Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins. Annu. Rev. Med. 38:175-94
4. Lee JO, Rieu P, Arnaout MA, Liddington R. 1995. Crystal structure of the A domain from the α subunit of integrin CR3 (CD11b/CD18). Cell 80:631-38
5. Emsley J, Knight CG, Farndale RW, Barnes MJ, Liddington RC. 2000. Structural basis of collagen recognition by integrin α2β1. Cell 101:47-56
6. Shimaoka M, Xiao T, Liu JH, Yang Y, Dong Y, et al. 2003. Structures of the αL I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation. Cell 112:99-111
7. Song G, Yang Y, Liu JH, Casasnovas JM, Shimaoka M, et al. 2005. An atomic resolution view of ICAM recognition in a complex between the binding domains of ICAM-3 and integrin αLβ2. Proc. Natl. Acad. Sci. USA 102:3366-71
8. Lee JO, Bankston LA, Arnaout MA, Liddington RC. 1995. Two conformations of the integrin A-domain (I-domain): a pathway for activation? Structure 3:1333-40
9. Shimaoka M, Shifman JM, Jing H, Takagi J, Mayo SL, Springer TA. 2000. Computational design of an integrin I domain stabilized in the open, high affinity conformation. Nat. Struct. Biol. 7:674-78
10. Jin M, Song G, Kim YS, Astrof N, Shimaoka M, et al. 2006. Directed evolution to probe protein allostery and integrin I domains of 200,000-fold higher affinity. Proc. Natl. Acad. Sci. USA 103:5758-63
11. Shimaoka M, Lu C, Palframan RT, von Andrian UH, McCormack A, et al. 2001. Reversibly locking a protein fold in an active conformation with a disulfide bond: integrin αL I domains with high affinity and antagonist activity in vivo. Proc. Natl. Acad. Sci. USA 98:6009-14
12. Jin M, Andricioaei I, Springer TA. 2004. Conversion between three conformational states of integrin I domains with a C-terminal pull spring studied with molecular dynamics. Structure 12:2137-47
13. Huang L, Shimaoka M, Rondon I, Roy I, Chang Q, et al. 2006. Identification and characterization of a human monoclonal antagonistic antibody AL-57 that preferentially binds the high-affinity form of lymphocyte function-associated antigen-1. J. Leukoc. Biol. 80:905-14
14. Shimaoka M, Kim M, Cohen EH, Yang W, Astrof N, et al. 2006. AL-57, a ligand-mimetic antibody to integrin LFA-1, reveals chemokine-induced affinity up-regulation in lymphocytes. Proc. Natl. Acad. Sci. USA 103:13991-96
15. Diamond MS, Garcia-Aguilar J, Bickford JK, Corbi AL, Springer TA. 1993. The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J. Cell Biol. 120:1031-43
16. Kallen J, Welzenbach K, Ramage P, Geyl D, Kriwacki R, et al. 1999. Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain. J. Mol. Biol. 292:1-9
17. Last-Barney K, Davidson W, Cardozo M, Frye LL, Grygon CA, et al. 2001. Binding site elucidation of hydantoin-based antagonists of LFA-1 using multidisciplinary technologies: evidence for the allosteric inhibition of a protein-protein interaction. J. Am. Chem. Soc. 123:5643-50
18. Liu G, Huth JR, Olejniczak ET, Mendoza R, DeVries P, et al. 2001. Novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intracellular adhesion molecule-1 interaction. 2. Mechanism of inhibition and structure-based improvement of pharmaceutical properties. J. Med. Chem. 44:1202-10
19. Lu C, Shimaoka M, Zang Q, Takagi J, Springer TA. 2001. Locking in alternate conformations of the integrin αLβ2 I domain with disulfide bonds reveals functional relationships among integrin domains. Proc. Natl. Acad. Sci. USA 98:2393-98
20. Lu C, Shimaoka M, Ferzly M, Oxvig C, Takagi J, Springer TA. 2001. An isolated, surface-expressed I domain of the integrin αLβ2 is sufficient for strong adhesive function when locked in the open conformation with a disulfide. Proc. Natl. Acad. Sci. USA 98:2387-92
21. 2-integrins and their cellular ligands. Eur. J. Biochem. 245:215-32
22. Song G, Lazar GA, Kortemme T, Shimaoka M, Desjarlais JR, et al. 2006. Rational design of ICAM-1 variants for antagonizing integrin LFA-1-dependent adhesion. J. Biol. Chem. 281:5042-49
23. Casasnovas JM, Springer TA, Liu J, Harrison SC, Wang J. 1997. The crystal structure of ICAM-2 reveals a distinctive integrin recognition surface. Nature 387:312-15
24. Yang Y, Jun CD, Liu J, Zhang RG, Jochimiak A, et al. 2004. Structural basis for dimerization of ICAM-1 on the cell surface. Mol. Cell 14:269-76
25. Reilly PL, Woska JR Jr, Jeanfavre DD, McNally E, Rothlein R, Bormann BJ. 1995. The native structure of intercellular adhesion molecule-1 (ICAM-1) is a dimer: correlation with binding to LFA-1. J. Immunol. 155:529-32
26. Miller J, Knorr R, Ferrone M, Houdei R, Carron CP, Dustin ML. 1995. Intercellular adhesion molecule-1 dimerization and its consequences for adhesion mediated by lymphocyte function associated-1. J. Exp. Med. 182:1231-41
27. Altieri DC, Morrissey JH, Edgington TS. 1988. Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: an alternative initiation of the coagulation protease cascade. Proc. Natl. Acad. Sci. USA 85:7462-66
28. Diamond MS, Staunton DE, de Fougerolles AR, Stacker SA, Garcia-Aguilar J, et al. 1990. ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18). J. Cell Biol. 111:3129-39
29. Vorup-Jensen T, Carman CV, Shimaoka M, Schuck P, Svitel J, Springer TA. 2005. Exposure of acidic residues as a danger signal for recognition of fibrinogen and other macromolecules by integrin αXβ2. Proc. Natl. Acad. Sci. USA 102:1614-19
30. Nermut MV, Green NM, Eason P, Yamada SS, Yamada KM. 1988. Electron microscopy and structural model of human fibronectin receptor. EMBO J. 7:4093-99
31. Xiong J-P, Stehle T, Diefenbach B, Zhang R, Dunker R, et al. 2001. Crystal structure of the extracellular segment of integrin αVβ3. Science 294:339-45
32. Xiong J-P, Stehle T, Zhang R, Joachimiak A, Freeh M, et al. 2002. Crystal structure of the extracellular segment of integrin αVβ3 in complex with an Arg-Gly-Asp ligand. Science 296:151-55
33. Takagi J, Petre BM, Walz T, Springer TA. 2002. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell 110:599-611
34. Takagi J, Strokovich K, Springer TA, Walz T. 2003. Structure of integrin α5β1 in complex with fibronectin. EMBO J. 22:4607-15
35. Kim M, Carman CV, Springer TA. 2003. Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science 301:1720-25
36. Xiao T, Takagi J, Wang J, Coller BS, Springer TA. 2004. Structural basis for allostery in integrins and binding of ligand-mimetic therapeutics to the platelet receptor for fibrinogen. Nature 432:59-67
37. Springer TA. 1997. Folding of the N-terminal, ligand-binding region of integrin α-subunits into a β-propeller domain. Proc. Natl. Acad. Sci. USA 94:65-72
38. Bilsland CA, Diamond MS, Springer TA. 1994. The leukocyte integrin p150,95 (CD11c/CD18) as a receptor for iC3b: activation by a heterologous β subunit and localization of a ligand recognition site to the I domain. J. Immunol. 152:4582-89
39. Huang C, Zang Q, Takagi J, Springer TA. 2000. Structural and functional studies with antibodies to the integrin β2 subunit: a model for the I-like domain. J. Biol. Chem. 275:21514-24
40. Xiong J-P, Stehle T, Goodman SL, Arnaout MA. 2004. A novel adaptation of the integrin PSI domain revealed from its crystal structure. J. Biol. Chem. 279:40252-54
41. Shi M, Sundramurthy K, Liu B, Tan SM, Law SK, Lescar J. 2005. The crystal structure of the plexin-semaphorin-integrin domain/hybrid domain/I-EGF1 segment from the human integrin β2 subunit at 1.8-Å resolution. J. Biol. Chem. 280:30586-93
42. Takagi J, Springer TA. 2002. Integrin activation and structural rearrangement. Immunol. Rev. 186:141-63
43. Nishida N, Xie C, Shimaoka M, Cheng Y, Walz T, Springer TA. 2006. Activation of leukocyte β2 integrins by conversion from bent to extended conformations. Immunity 25:583-94
44. Honda S, Tomiyama Y, Pelletier AJ, Annis D, Honda Y, et al. 1995. Topography of ligand-induced binding sites, including a novel cation-sensitive epitope (AP5) at the amino terminus, of the human integrin β3 subunit. J. Biol. Chem. 270:11947-54
45. Lu C, Ferzly M, Takagi J, Springer TA. 2001. Epitope mapping of antibodies to the C-terminal region of the integrin β2 subunit reveals regions that become exposed upon receptor activation. J. Immunol. 166:5629-37
46. Mould AP, Travis MA, Barton SJ, Hamilton JA, Askari JA, et al. 2005. Evidence that monoclonal antibodies directed against the integrin β subunit plexin/semaphorin/integrin domain stimulate function by inducing receptor extension. J. Biol. Chem. 280:4238-46
47. Peterson JA, Nyree CE, Newman PJ, Aster RH. 2003. A site involving the "hybrid" and PSI homology domains of GPIIIa (β3-integrin subunit) is a common target for antibodies associated with quinine-induced immune thrombocytopenia. Blood 101:937-42
48. 2+-dependent epitope in the thigh/genu interface upon activation. Proc. Natl. Acad. Sci. USA 101:15422-27
49. Chen JF, Salas A, Springer TA. 2003. Bistable regulation of integrin adhesiveness by a bipolar metal ion cluster. Nat. Struct. Biol. 10:995-1001
50. Mould AP, Barton SJ, Askari JA, Craig SE, Humphries MJ. 2003. Role of ADMIDAS cation-binding site in ligand recognition by integrin α5β1. J. Biol. Chem. 278:51622-29
51. Chen JF, Yang W, Kim M, Carman CV, Springer TA. 2006. Regulation of outside-in signaling and affinity by the β2 I domain of integrin αLβ2. Proc. Natl. Acad. Sci. USA 103:13991-96
52. Huth JR, Olejniczak ET, Mendoza R, Liang H, Harris EA, et al. 2000. NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding. Proc. Natl. Acad. Sci. USA 97:5231-36
53. Alonso JL, Essafi M, Xiong J-P, Stehle T, Arnaout MA. 2002. Does the integrin αA domain act as a ligand for its βA domain? Curr. Biol. 12:R340-42
54. Yang W, Shimaoka M, Salas A, Takagi J, Springer TA. 2004. Inter-subunit signal transmission in integrins by a receptor-like interaction with a pull spring. Proc. Natl. Acad. Sci. USA 101:2906-11
55. Welzenbach K, Hommel U, Weitz-Schmidt G. 2002. Small molecule inhibitors induce conformational changes in the I domain and the I-like domain of lymphocyte function-associated antigen-1: molecular insights into integrin inhibition. J. Biol. Chem. 277:10590-98
56. Shimaoka M, Salas A, Yang W, Weitz-Schmidt G, Springer TA. 2003. Small molecule integrin antagonists that bind to the β2 subunit I-like domain and activate signals in one direction and block them in another. Immunity 19:391-402
57. Salas A, Shimaoka M, Kogan AN, Harwood C, von Andrian UH, Springer TA. 2004. Rolling adhesion through an extended conformation of integrin αLβ2 and relation to α I and β I-like domain interaction. Immunity 20:393-406
58. Knorr R, Dustin ML. 1997. The lymphocyte function-associated antigen 1 I domain is a transient binding module for intercellular adhesion molecule (ICAM)-1 and ICAM-1 in hydrodynamic flow. J. Exp. Med. 186:719-30
59. Salas A, Shimaoka M, Chen SQ, Carman CV, Springer TA. 2002. Transition from rolling to firm adhesion is regulated by the conformation of the I domain of the integrin LFA-1. J. Biol. Chem. 277:50255-62
60. Iwasaki K, Mitsuoka K, Fujiyoshi Y, Fujisawa Y, Kikuchi M, et al. 2005. Electron tomography reveals diverse conformations of integrin α IIbβ3 in the active state. J. Struct. Biol. 150:259-67
61. Mould AP, Symonds EJ, Buckley PA, Grossmann JG, McEwan PA, et al. 2003. Structure of an integrin-ligand complex deduced from solution X-ray scattering and site-directed mutagenesis. J. Biol. Chem. 278:39993-99
62. Luo BH, Springer TA, Takagi J. 2003. Stabilizing the open conformation of the integrin headpiece with a glycan wedge increases affinity for ligand. Proc. Natl. Acad. Sci. USA 100:2403-8
63. Luo BH, Strokovich K, Walz T, Springer TA, Takagi J. 2004. Allosteric β1 integrin antibodies that stabilize the low affinity state by preventing the swing-out of the hybrid domain. J. Biol. Chem. 279:27466-71
64. Tng E, Tan SM, Ranganathan S, Cheng M, Law SK. 2004. The integrin αLβ2 hybrid domain serves as a link for the propagation of activation signal from its stalk regions to the I-like domain. J. Biol. Chem. 279:54334-39
65. Mould AP, Barton SJ, Askari JA, McEwan PA, Buckley PA, et al. 2003. Conformational changes in the integrin βA domain provide a mechanism for signal transduction via hybrid domain movement. J. Biol. Chem. 278:17028-35
66. Tang RH, Tng E, Law SK, Tan SM. 2005. Epitope mapping of monoclonal antibody to integrin αLβ2 hybrid domain suggests different requirements of affinity states for intercellular adhesion molecules (ICAM)-1 and ICAM-3 binding. J. Biol. Chem. 280:29208-16
67. Arnaout MA, Mahalingam B, Xiong J-P. 2005. Integrin structure, allostery, and bidirectional signaling. Annu. Rev. Cell Dev. Biol. 21:381-410
68. Luo BH, Springer TA. 2006. Integrin structures and conformational signaling. Curr. Opin. Cell Biol. 18:579-86
69. Adair BD, Xiong J-P, Maddock C, Goodman SL, Arnaout MA, Yeager M. 2005. Three-dimensional EM structure of the ectodomain of integrin αVβ3 in a complex with fibronectin. J. Cell Biol. 168:1109-18
70. Robinson MK, Andrew D, Rosen H, Brown D, Ortlepp S, et al. 1992. Antibody against the Leu-CAM β-chain (CD18) promotes both LFA-1-and CR3-dependent adhesion events. J. Immunol. 148:1080-85
71. Andrew D, Shock A, Ball E, Ortlepp S, Bell J, Robinson M. 1993. KIM185, a monoclonal antibody to CD18 which induces a change in the conformation of CD18 and promotes both LFA-1- and CR3-dependent adhesion. Eur. J. Immunol. 23:2217-22
72. Evangelista V, Manarini S, Rotondo S, Martelli N, Polischuk R, et al. 1996. Platelet/polymorphonuclear leukocyte interaction in dynamic conditions: evidence of adhesion cascade and cross talk between P-selectin and the β2 integrin CD11b/CD18. Blood 88:4183-94
73. Takami M, Herrera R, Petruzzelli L. 2001. Mac-1-dependent tyrosine phosphorylation during neutrophil adhesion. Am. J. Physiol. Cell Physiol. 280:C1045-56
74. Petruzzelli L, Maduzia L, Springer TA. 1995. Activation of LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) mimicked by an antibody directed against CD18. J. Immunol. 155:854-66
75. Kim M, Carman CV, Yang W, Salas A, Springer TA. 2004. The primacy of affinity over clustering in regulation of adhesiveness of the integrin αLβ2. J. Cell Biol. 167:1241-53
76. Shimaoka M, Lu C, Salas A, Xiao T, Takagi J, Springer TA. 2002. Stabilizing the integrin αM inserted domain in alternative conformations with a range of engineered disulfide bonds. Proc. Natl. Acad. Sci. USA 99:16737-41
77. Takagi J, Beglova N, Yalamanchili P, Blacklow SC, Springer TA. 2001. Definition of EGF-like, closely interacting modules that bear activation epitopes in integrin β subunits. Proc. Natl. Acad. Sci. USA 98:11175-80
78. Yang W, Shimaoka M, Chen JF, Springer TA. 2004. Activation of integrin β subunit I-like domains by one-turn C-terminal α-helix deletions. Proc. Natl. Acad. Sci. USA 101:2333-38
79. Takagi J, Erickson HP, Springer TA. 2001. C-terminal opening mimics "inside-out" activation of integrin α5β1. Nat. Struct. Biol. 8:412-16
80. IIb. Science 254:845-47
81. O'Toole TE, Katagiri Y, Faull RJ, Peter K, Tamura R, et al. 1994. Integrin cytoplasmic domains mediate inside-out signal transduction. J. Cell Biol. 124:1047-59
82. Hughes PE, Diaz-Gonzalez F, Leong L, Wu C, McDonald JA, et al. 1996. Breaking the integrin hinge. J. Biol. Chem. 271:6571-74
83. Lu C, Springer TA. 1997. The α subunit cytoplasmic domain regulates the assembly and adhesiveness of integrin lymphocyte function-associated antigen-1 (LFA-1). J. Immunol. 159:268-78
84. Lu C, Takagi J, Springer TA. 2001. Association of the membrane-proximal regions of the α and β subunit cytoplasmic domains constrains an integrin in the inactive state. J. Biol. Chem. 276:14642-48
85. 3 "inside-out" activation as regulated by its cytoplasmic face. Cell 110:587-97
86. Weljie AM, Hwang PM, Vogel HJ. 2002. Solution structures of the cytoplasmic tail complex from platelet α IIb- and β3-subunits. Proc. Natl. Acad. Sci. USA 99:5878-83
87. Ulmer TS, Yaspan B, Ginsberg MH, Campbell ID. 2001. NMR analysis of structure and dynamics of the cytosolic tails of integrin α IIbβ3 in aqueous solution. Biochemistty 40:7498-508
88. Vinogradova O, Vaynberg J, Kong X, Haas TA, Plow EF, Qin J. 2004. Membrane-mediated structural transitions at the cytoplasmic face during integrin activation. Proc. Natl. Acad. Sci. USA 101:4094-99
89. Katagiri K, Maeda A, Shimonaka M, Kinashi T. 2003. RAPL, a novel Rap1-binding molecule, mediates Rap1-induced adhesion through spatial regulation of LFA-1. Nat. Immunol. 4:741-48
90. Calderwood DA, Zent R, Grant R, Rees DJ, Hynes RO, Ginsberg MH. 1999. The talin head domain binds to integrin β subunit cytoplasmic tails and regulates integrin activation. J. Biol. Chem. 274:28071-74
91. Garcia-Alvarez B, de Pereda JM, Calderwood DA, Ulmer TS, Critchley D, et al. 2003. Structural determinants of integrin recognition by talin. Mol. Cell 11:49-58
92. Tadokoro S, Shattil SJ, Eto K, Tai V, Liddington RC, et al. 2003. Talin binding to integrin β tails: a final common step in integrin activation. Science 302:103-6
93. Calderwood DA, Huttenlocher A, Kiosses WB, Rose DM, Woodside DG, et al. 2001. Increased filamin binding to β-integrin cytoplasmic domains inhibits cell migration. Nat. Cell Biol. 3:1060-68
94. Chang DD, Hoang BQ, Liu J, Springer TA. 2002. Molecular basis for interaction between Icap1α PTB domain and β1 integrin. J. Biol. Chem. 277:8140-45
95. Ulmer TS, Calderwood DA, Ginsberg MH, Campbell ID. 2003. Domain-specific interactions of talin with the membrane-proximal region of the integrin β3 subunit. Biochemistry 42:8307-12
96. Kiema T, Lad Y, Jiang P, Oxley CL, Baldassarre M, et al. 2006. The molecular basis of filamin binding to integrins and competition with talin. Mol. Cell 21:337-47
97. Luo BH, Springer TA, Takagi J. 2004. A specific interface between integrin transmembrane helices and affinity for ligand. PLoS Biol. 2:776-86
98. Luo BH, Carman CV, Takagi J, Springer TA. 2005. Disrupting integrin transmembrane domain heterodimerization increases ligand binding affinity, not valency or clustering. Proc. Natl. Acad. Sci. USA 102:3679-84
99. Li W, Metcalf DG, Gorelik R, Li R, Mitra N, et al. 2005. A push-pull mechanism for regulating integrin function. Proc. Natl. Acad. Sci. USA 102:1424-29
100. Partridge AW, Liu S, Kim S, Bowie JU, Ginsberg MH. 2005. Transmembrane domain packing stabilizes integrin α IIbβ3 in the low affinity state. J. Biol. Chem. 280:7294-300
101. Bazzoni G, Ma L, Blue ML, Hemler ME. 1998. Divalent cations and ligands induce conformational changes that are highly divergent among β1 integrins. J. Biol. Chem. 273:6670-78
102. Chen CS, Tan J, Tien J. 2004. Mechanotransduction at cell-matrix and cell-cell contacts. Annu. Rev. Biomed. Eng. 6:275-302
103. Astrof NS, Salas A, Shimaoka M, Chen JF, Springer TA. 2006. The importance of force linkage in mechanochemistry of adhesion receptors. Biochemistry 45:15020-28
104. Carman CV, Springer TA. 2003. Integrin avidity regulation: Are changes in affinity and conformation underemphasized? Curr. Opin. Cell Biol. 15:547-56
105. Bazzoni G, Hemler ME. 1998. Are changes in integrin affinity and conformation overemphasized? Trends Biochem. Sci. 23:30-34
106. Constantin G, Majeed M, Giagulli C, Piccib L, Kim JY, et al. 2000. Chemokines trigger immediate β2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow. Immunity 13:759-69
107. Chan JR, Hyduk SJ, Cybulsky MI. 2001. Chemoattractants induce rapid and transient upregulation of monocyte α4 integrin affinity for vascular adhesion molecule 1 which mediates arrest: an early step in the process of emmigration. J. Exp. Med. 193:1149-58
108. Chan JR, Hyduk SJ, Cybulsky MI. 2003. Detecting rapid and transient upregulation of leukocyte integrin affinity induced by chemokines and chemoattractants. J. Immunol. Methods 273:43-52
109. Lollo BA, Chan KW, Hanson EM, Moy VT, Brian AA. 1993. Direct evidence for two affinity states for lymphocyte function-associated antigen 1 on activated T cells. J. Biol. Chem. 268:21693-700
110. van Kooyk Y, Figdor CG. 2000. Avidity regulation of integrins: the driving force in leukocyte adhesion. Curr. Opin. Cell Biol. 12:542-47
111. 2+- and calcineurin-dependent recycling of an integrin to the front of migrating neutrophils. Nature 377:75-79
112. Tohyama Y, Katagiri K, Pardi R, Lu C, Springer TA, Kinashi T. 2003. The critical cytoplasmic regions of the αL/β2 integrin in Rap1-induced adhesion and migration. Mol. Biol. Cell 14:2570-82
113. Shimonaka M, Katagiri K, Kakayama T, Fujita N, Tsuruo T, et al. 2003. Rap1 translates chemokine signals to integrin activation, cell polarization, and motility across vascular endothelium under flow. J. Cell Biol. 161:417-27
114. Li R, Mitra N, Gratkowski H, Vilaire G, Litvinov SV, et al. 2003. Activation of integrin α IIbβ3 by modulation of transmembrane helix associations. Science 300:795-98
115. Jin T, Li J. 2002. Dynamitin controls β2 integrin avidity by modulating cytoskeletal constraint on integrin molecules. J. Biol. Chem. 277:32963-69
116. Kucik DF, Dustin ML, Miller JM, Brown EJ. 1996. Adhesion-activating phorbol ester increases the mobility of leukocyte integrin LFA-1 in cultured lymphocytes. J. Clin. Invest. 97:2139-44
117. Buensuceso C, De Virgilio M, Shattil SJ. 2003. Detection of integrin α IIbβ3 clustering in living cells. J. Biol. Chem. 278:15217-24
118. Peters IM, van Kooyk Y, van Vliet SJ, de Grooth BG, Figdor CG, Greve J. 1999. 3D single-particle tracking and optical trap measurements on adhesion proteins. Cytometry 36:189-94
119. Smith A, Carrasco YR, Stanley P, Kieffer N, Batista FD, Hogg N. 2005. A talin-dependent LFA-1 focal zone is formed by rapidly migrating T lymphocytes. J. Cell Biol. 170:141-51
120. Felsenfeld DP, Choquet D, Sheetz MP. 1996. Ligand binding regulates the directed movement of β1 integrins on fibroblasts. Nature 383:438-40
121. Cairo CW, Mirchev R, Golan DE. 2006. Cytoskeletal regulation couples LFA-1 conformational changes to receptor lateral mobility and clustering. Immunity 25:297-308
122. Shattil SJ, Newman PJ. 2004. Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood 104:1606-15
123. Grashoff C, Thievessen I, Lorenz K, Ussar S, Fassler R. 2004. Integrin-linked kinase: integrin's mysterious partner. Curr. Opin. Cell Biol. 16:565-71
124. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, et al. 2003. Cell migration: integrating signals from front to back. Science 302:1704-9
125. Guo W, Giancotti FG. 2004. Integrin signaling during tumor progression. Nat. Rev. Mol. Cell Biol. 5:816-26
126. Van der Vieren M, Crowe DT, Hoekstra D, Vazeux R, Hoffman PA, et al. 1999. The leukocyte integrin αDβ2 binds VCAM-1: evidence for a binding interface between I domain and VCAM-1. J. Immunol. 163:1984-90
127. Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto TK, et al. 1995. White Cell Differentiation Antigens. New York: Oxford Univ. Press
128. Kishimoto TK, Kikutani H, von dem Borne AEGK, Goyert SM, Mason DY, et al. 1997. White Cell Differentiation Antigens. New York: Garland